iSAM Funds (UK)’s Vir Biotechnology VIR Stock Holding History

iSAM Funds (UK)’s Portfolio VIR Stock Details VIR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-17,086	Closed	-$97.6K	–	711
2025 Q3	$97.6K	Buy	+17,086	New	+$87.4K	0.02%	502

Other funds holding VIR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SIAU

SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return

AVM

Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

GSK plc London $602M AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return

iSAM Funds (UK)'s VIR Position: Q4 2025 in Review

iSAM Funds (UK) sold out of Vir Biotechnology (VIR) in Q4 2025, closing a stake of 17,086 shares — an estimated $97.6K sold.

iSAM Funds (UK) first reported a position in VIR in Q3 2025 and held it in 1 quarter. The position peaked at $97.6K in Q3 2025. 218 funds tracked by Wall St. Rank hold VIR as of Q4 2025.

iSAM Funds (UK) reported no remaining Vir Biotechnology position as of Q4 2025 after selling out during the quarter.
iSAM Funds (UK) sold 17,086 Vir Biotechnology shares in Q4 2025, an estimated $97.6K.
iSAM Funds (UK) first reported a position in Vir Biotechnology in Q3 2025 and held it in 1 quarter.
iSAM Funds (UK)'s Vir Biotechnology position peaked at $97.6K in Q3 2025.
218 funds tracked by Wall St. Rank held Vir Biotechnology as of Q4 2025.

Based on iSAM Funds (UK)'s 13F filing for Q4 2025, filed 17 Feb 2026.